Contribution profit per booking rises 30% to $12.94; contribution margin expands 800 basis points to 55% of revenue; net loss attributable to shareholders narrows 43% to $14.62 millionBENGALURU, India, July 14, 2026 /PRNewswire/ — Zoomcar Holdings, Inc. (OTCQB:…
BFA Law is investigating Barry Diller’s $48.30 per share offer to acquire MGM Resorts International; current shareholders are notified to contact the firm.NEW YORK, July 14, 2026 /PRNewswire/ — Leading securities law firm Bleichmar Fonti & Auld LLP announces…
Award brings TOTE Services’ proven Vessel Construction Manager experience to a mission-critical U.S. Navy and Marine Corps shipbuilding programJACKSONVILLE, Fla., July 13, 2026 /PRNewswire/ — TOTE Services, LLC, has been awarded a contract by the Portfolio Acquisition Executive…
NEW YORK, July 13, 2026 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of BitGo Holdings, Inc. (NYSE: BTGO): (i) Class A common stock pursuant and/or traceable to the registration statement and…
TEL AVIV, Israel, July 13, 2026 /PRNewswire/ — SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors, announced today that it has entered into a securities purchase agreement with certain institutional…
WARSAW, Ind., July 13, 2026 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its second quarter earnings conference call will be webcast on Wednesday, August 5, 2026 at 8:30…
LOS ANGELES, July 13, 2026 /PRNewswire/ — The DJS Law Group reminds investors of a class action lawsuit against Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: PHR) for violations of §§10(b) and 20(a) of the Securities Exchange Act…
SAN FRANCISCO, July 11, 2026 /PRNewswire/ — Corgi Insurance today announced that Robert E. “Rob” Barlow Jr., a veteran insurance executive with more than 30 years of leadership experience, will support the company’s continued program expansion across community…
Presented interim FRONTIER4 data evaluate the long-term safety and efficacy of investigational denecimig across once-weekly, once-every-two-weeks, and once-monthly dosing in hemophilia A participants of all ages and disease severities1,2Denecimig is an investigational subcutaneous FVIIIa-mimetic antibody under review with…
NEW YORK, July 10, 2026 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Via Transportation, Inc. (NYSE: VIA) pursuant and/or traceable to the registration statement and related prospectus (collectively, the…